medigraphic.com

2016, Number 2

Rev cubana med 2016; 55 (2)

Clinical characterization of patients with familial hypercholesterolemia

Herrera GA, Soto MJ, Tamargo BTO, Bermúdez ML

Language: Spanish
References: 19
Page: 130-140
PDF size: 150.30 Kb.


ABSTRACT

Introduction: familial hypercholesterolemia is a genetic disorder associated with premature coronary disease due to elevated LDL cholesterol.
Objective: characterize familial hypercholesterolemia.
Methods: this is a retrospective case series study. WHO-MedPed scale was applied to 538 patients and the final sample was composed of 393 patients with score ≥ 3.
Results: there was female predominance and ageds under 60 of both sexes. Significant difference between the different strata was found by family history, but not for the risk factors. Early coronary disease and clinical manifestations as xanthomas were more frequent in the positive patients.
Conclusion: the frequency of familial hypercholesterolemia was high. Clinical manifestations are more evident in patients with positive criteria for the disorder under study. Subclinical atherosclerosis is significantly present in patients with positive criteria of familial hypercholesterolemia.


REFERENCES

  1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. En: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. Vol. II. New York: McGraw-Hill; 2001. Pp. 2863-913.

  2. Rader DJ, Cohen J, Hobbs HH. Monogenic hypercholesterolemia: New insights in pathogenesis and treatment. J Clin Invest. 2003;111:1795-803.

  3. Daniels SR, Gidding SS, de Ferranti SD. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5:30-7.

  4. Singh S, Bittner V. Familial Hypercholesterolemia. Epidemiology, diagnosis and screening. Curr Atheroscler Rep. 2015;17:482-5.

  5. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ. 1991;303:893-6.

  6. World Health Organization. Familial hypercholesterolemia -report of a second WHO Consultation. Geneva, Switzerland: World Health Organization, 1999. (WHO publication no. WHO/HGN/FH/CONS/99.2).

  7. Nasiff-Hadad A, Klaindor SB, Jiménez PR, Baldor NF. Prevalencia de hipercolesterolemia en la población adulta del municipio Habana Vieja. Rev Cubana Med Gen Integr. 1992;8(4):293-306.

  8. Nordestgaard BG, Chapman MJ, Humphries SE. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478-3490a.

  9. Peláez O. Esperanza de vida alcanza 78,45 años. Granma. 25 de mayo de 2015. [citado 25 May 2015 ] Disponible en: http://www.granma.cu/cuba/2015-05- 25/esperanza-de-vida-alcanza-7845-anos

  10. Najam O, Ray KK. Familial Hypercholesterolemia: a Review of the Natural History, Diagnosis, and Management. Cardiol Ther. 2015;4(1):25-38.

  11. Soska V, Freiberger T, Cifkova R, Lanska V, Vrablik M, Fajkusova L, et al. Plasma HDL-cholesterol and triglyceride levels in familial hypercholesterolemia: data from the MedPed CZ database and the Czech population. Clin Chim Acta. 2011 May 12;412(11-12):920-4.

  12. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292:331-7.

  13. Vogt A, Keller C, Heigl C, Weiss N, Zöllner N. Two forms of familial hypercholesterolemia: differences in cardiovascular risk factors, cardiac and extracardiac atherosclerosis. Dtsch Med Wochenschr. 2014 Dec;139(50):2573-7.

  14. Pereira C, Miname M, Makdisse M, Kalil Filho R, Santos RD. Association of peripheral arterial and cardiovascular diseases in familial hypercholesterolemia. Arq Bras Cardiol. 2014 Aug;103(2):118-23.

  15. Kong MX, Zhang Q, Cao L, Zhao C, Ru GQ, Bi Q. Familial hypercholesterolaemia with tuberous and tendinous xanthomas: case report and mutation analysis. Clin Exp Dermatol. 2015 Mar 26.

  16. Merkens LS, Myrie SB, Steiner RD, Pagon RA, Adam MP, Ardinger HH. Sitosterolemia. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2014. [citado 4 Abr. 2013] Disponible en: http://www.ncbi.nlm.nih.gov/books/NBK131810/

  17. Feinstein SB, Voci P, Pizzuto F. Noninvasive surrogate markers of atherosclerosis. Am J Cardiol. 2002;89:31-43.

  18. Cenarro A, de Castro Orós I, Murillo Civera. Hipercolesterolemias genéticas. Medicine. 2013;11:2396-401.

  19. Talmud PJ, Shah S, Whittall R, Futema M, Howard P, Cooper JA, et al. Useof low-density lipoprotein cholesterol gene score to distinguish patients withpolygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet. 2013;381:1293-301.




2020     |     www.medigraphic.com